AIMS -To improve local control and survival
-To improve organ preservation
-To improve quality of life
-To optimize external irradiation fractionation schemes
-To combine drugs and irradiation to modify the radiation response
-To use adjuvant systemic treatment
-To promote quality assurance programmes in radiotherapy departments
-To assess late effects on normal tissues
STRATEGIES
-Elaboration of new randomized trials aiming at the most efficient integration of radiotherapy with other treatment modalities (i.e. surgery, chemotherapy, hormone therapy) into a whole range of cancer sites, in close cooperation with other EORTC groups or international organisations
-Integration of innovative modalities into radiotherapy such as new classes of therapeutic agents (radiation modifiers, anti-angiogenesis compounds and gene therapy)
-Integration of novel radiation techniques such as IMRT, allowing dose-escalation studies
EORTC |
